I12.0

Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease

## Overview of Hypertensive Chronic Kidney Disease with Stage 5 CKD or ESRD (I12.0) Hypertensive chronic kidney disease (CKD) with stage 5 CKD or end-stage renal disease (ESRD), coded as I12.0, describes a condition where long-standing, uncontrolled hypertension has led to severe and irreversible damage to the kidneys, culminating in the most advanced stages of kidney failure. This diagnosis signifies that the kidneys' ability to filter waste products from the blood has significantly diminished, requiring renal replacement therapy (dialysis or kidney transplant) for survival. ### Pathophysiology Chronic hypertension causes structural changes within the kidney, primarily affecting the small blood vessels (arterioles and glomeruli). Over time, the sustained high pressure leads to nephrosclerosis, a hardening and narrowing of the renal arteries and arterioles. This reduces blood flow to the nephrons (the functional units of the kidney), causing ischemia and gradual loss of functional renal tissue. The glomeruli, responsible for initial blood filtration, become sclerosed, and the tubules and interstitial tissue become fibrotic. This progressive damage leads to a decline in the glomerular filtration rate (GFR), which is a key measure of kidney function. ### Stages of Chronic Kidney Disease CKD is classified into five stages based on GFR. Stage 5 CKD is defined by a GFR less than 15 mL/min/1.73 m², indicating severe kidney damage and significantly reduced kidney function. ESRD is a subset of Stage 5 CKD where the kidney function is so low that renal replacement therapy is necessary to maintain life. ### Clinical Manifestations The clinical presentation of I12.0 is dominated by symptoms of uremia, which result from the accumulation of waste products and fluid-electrolyte imbalances due to the kidneys' inability to perform their excretory, regulatory, and endocrine functions. Patients often present with systemic symptoms affecting multiple organ systems. ### Diagnosis Diagnosis involves a combination of medical history (especially long-standing hypertension), physical examination, and laboratory tests. Key lab findings include significantly elevated serum creatinine and urea nitrogen, severely decreased GFR, electrolyte imbalances (e.g., hyperkalemia, hyperphosphatemia), anemia, and metabolic acidosis. Urinalysis may show proteinuria. Renal imaging (ultrasound) can reveal small, shrunken kidneys consistent with chronic damage.

Clinical Symptoms

  • Severe fatigue and weakness
  • Nausea, vomiting, and loss of appetite (anorexia)
  • Swelling (edema), especially in legs, feet, and hands
  • Shortness of breath (due to fluid overload or anemia)
  • Muscle cramps and restless legs
  • Persistent itching (pruritus)
  • Changes in urination (e.g., decreased urine output, or initially increased frequency at night in earlier stages)
  • Difficulty concentrating, confusion, or cognitive impairment
  • Pale skin (pallor) due to anemia
  • Bone pain or fractures (renal osteodystrophy)
  • Headaches
  • Metallic taste in mouth

Common Causes

  • Long-standing, uncontrolled essential (primary) hypertension
  • Secondary hypertension (e.g., renovascular hypertension, primary aldosteronism) leading to progressive kidney damage
  • Lack of adherence to antihypertensive medication regimens
  • Inadequate control of co-morbid conditions such as diabetes mellitus, which can accelerate kidney damage when combined with hypertension
  • Genetic predisposition to hypertension and/or kidney disease
  • Lifestyle factors contributing to hypertension progression (e.g., high-sodium diet, obesity, smoking, physical inactivity)

Documentation & Coding Tips

Explicitly link hypertension as the etiology of chronic kidney disease and specify the current CKD stage.

Example: Poor Documentation: 'Patient with HTN and CKD Stage 5. On hemodialysis.' (Lacks causal link, specificity for billing and HCC).Excellent Documentation: 'Patient is a 68-year-old male with long-standing, poorly controlled **essential hypertension (I10)**, which has progressed to **chronic kidney disease stage 5 (N18.5)**. Patient has been on thrice-weekly hemodialysis for End-Stage Renal Disease (ESRD) for the past 2 years. Reviewed recent labs showing GFR <15 mL/min/1.73m^2 and elevated creatinine of 7.2 mg/dL. He continues to experience fluid retention requiring aggressive ultrafiltration during dialysis sessions.'Billing Focus: Explicitly states 'essential hypertension' and 'chronic kidney disease stage 5' with a clear causal link ('progressed to'). 'ESRD' provides further specificity.Risk Adjustment: 'Long-standing, poorly controlled hypertension' and 'CKD Stage 5' (which maps to HCC 18, ESRD) significantly impact risk adjustment, showing high disease burden and acuity. 'Fluid retention' indicates ongoing symptom management.

Billing Focus: Clearly state 'hypertensive chronic kidney disease' and the specific stage (Stage 5 or ESRD). Ensure the link is explicit, not just co-occurring diagnoses. Mention treatment like hemodialysis.

Document all complications and comorbidities directly related to or exacerbated by hypertensive CKD Stage 5/ESRD.

Example: Poor Documentation: 'Patient with I12.0. Also has anemia and hyperkalemia.' (Lacks detail, linkage, and treatment context).Excellent Documentation: 'Patient with **hypertensive chronic kidney disease with ESRD (I12.0)**, currently on hemodialysis. Presents with worsening fatigue. Labs confirm **CKD-related anemia (D63.1)**, Hgb 9.2 g/dL, managed with erythropoiesis-stimulating agents and IV iron during dialysis. Also notes chronic, well-controlled **secondary hyperparathyroidism (N25.81)** due to ESRD, monitoring PTH levels, currently stable on cinacalcet. Recent ECG shows no signs of hyperkalemia, K+ is 4.9 mEq/L, stable with dietary restrictions and potassium binder PRN.'Billing Focus: Specificity for anemia ('CKD-related anemia') and hyperparathyroidism ('secondary hyperparathyroidism due to ESRD'). Links these directly to the primary diagnosis. Risk Adjustment: 'CKD-related anemia' (HCC 19) and 'secondary hyperparathyroidism' (HCC 21) are distinct HCCs, demonstrating additional disease burden and increasing risk score. Documentation of active management (ESAs, iron, cinacalcet, dietary restrictions) further supports the complexity.

Billing Focus: Identify and document specific complications of ESRD such as anemia of chronic kidney disease, hyperkalemia, secondary hyperparathyroidism, and cardiovascular complications, ensuring they are linked to the ESRD.

Clearly describe the patient's current management plan, including dialysis status, medication regimen, and any changes or adjustments.

Example: Poor Documentation: 'Patient continues dialysis. Meds reviewed.' (Lacks specific details for ongoing care and complexity).Excellent Documentation: 'Patient maintains a stable thrice-weekly hemodialysis schedule via left arm AV fistula, with no access complications noted today. Current medication regimen includes lisinopril 10 mg daily (BP 138/82 mmHg, target <140/90 mmHg), carvedilol 12.5 mg BID for concurrent systolic heart failure, calcium acetate with meals for hyperphosphatemia, and darbepoetin alfa 60 mcg weekly. Patient tolerating regimen well. Discussed adherence to fluid restrictions and low-sodium, low-potassium diet. Scheduled follow-up in 3 months with Nephrology. Medical decision making is high due to multiple chronic conditions, complex medication management, and ongoing dialysis therapy.'Billing Focus: Details of dialysis access and frequency, specific medications, and their dosages demonstrate active management. The explicit mention of 'medical decision making is high' supports higher-level E&M coding.Risk Adjustment: Documentation of specific medications (lisinopril, carvedilol, calcium acetate, darbepoetin alfa) and ongoing dialysis indicates active treatment of multiple severe conditions (hypertension, CKD, heart failure, hyperphosphatemia, anemia), validating the high risk profile (e.g., HCCs for ESRD, CHF, hypertension).

Billing Focus: Document type and frequency of dialysis, access site, and any complications. List all active medications with dosages and indications. Clearly justify medical necessity for high-level E&M services.

Relevant CPT Codes

Related Diagnoses

Hierarchy